12062 related articles for article (PubMed ID: 11497284)
1. Anticancer activity of an aqueous mistletoe extract (AME) in syngeneic murine tumor models.
Burger AM; Mengs U; Schüler JB; Fiebig HH
Anticancer Res; 2001; 21(3B):1965-8. PubMed ID: 11497284
[TBL] [Abstract][Full Text] [Related]
2. Antitumoral effects of an intravesically applied aqueous mistletoe extract on urinary bladder carcinoma MB49 in mice.
Mengs U; Schwarz T; Bulitta M; Weber K
Anticancer Res; 2000; 20(5B):3565-8. PubMed ID: 11131663
[TBL] [Abstract][Full Text] [Related]
3. Effects of a standardized mistletoe preparation on metastatic B16 melanoma colonization in murine lungs.
Weber K; Mengs U; Schwarz T; Hajto T; Hostanska K; Allen TR; Weyhenmeyer R; Lentzen H
Arzneimittelforschung; 1998 May; 48(5):497-502. PubMed ID: 9638318
[TBL] [Abstract][Full Text] [Related]
4. Antiproliferative activity of an aqueous mistletoe extract in human tumor cell lines and xenografts in vitro.
Burger AM; Mengs U; Schüler JB; Fiebig HH
Arzneimittelforschung; 2001 Sep; 51(9):748-57. PubMed ID: 11642008
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic activity and absence of tumor growth stimulation of standardized mistletoe extracts in human tumor models in vitro.
Kelter G; Schierholz JM; Fischer IU; Fiebig HH
Anticancer Res; 2007; 27(1A):223-33. PubMed ID: 17352237
[TBL] [Abstract][Full Text] [Related]
6. No evidence of stimulation of human tumor cell proliferation by a standardized aqueous mistletoe extract in vitro.
Burger AM; Mengs U; Kelter G; Schüler JB; Fiebig HH
Anticancer Res; 2003; 23(5A):3801-6. PubMed ID: 14666680
[TBL] [Abstract][Full Text] [Related]
7. In vitro effects of mistletoe extracts and mistletoe lectins. Cytotoxicity towards tumor cells due to the induction of programmed cell death (apoptosis).
Janssen O; Scheffler A; Kabelitz D
Arzneimittelforschung; 1993 Nov; 43(11):1221-7. PubMed ID: 8292069
[TBL] [Abstract][Full Text] [Related]
8. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals.
Hidvégi M; Ráso E; Tömösközi-Farkas R; Paku S; Lapis K; Szende B
Anticancer Res; 1998; 18(4A):2353-8. PubMed ID: 9703878
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral application of standardized mistletoe extracts down regulates tumor weight via decreased cell proliferation, increased apoptosis and necrosis in a murine model.
Beuth J; Ko HL; Schneider H; Tawadros S; Kasper HU; Zimst H; Schierholz JM
Anticancer Res; 2006; 26(6B):4451-6. PubMed ID: 17201168
[TBL] [Abstract][Full Text] [Related]
10. CEP-7055: a novel, orally active pan inhibitor of vascular endothelial growth factor receptor tyrosine kinases with potent antiangiogenic activity and antitumor efficacy in preclinical models.
Ruggeri B; Singh J; Gingrich D; Angeles T; Albom M; Yang S; Chang H; Robinson C; Hunter K; Dobrzanski P; Jones-Bolin S; Pritchard S; Aimone L; Klein-Szanto A; Herbert JM; Bono F; Schaeffer P; Casellas P; Bourie B; Pili R; Isaacs J; Ator M; Hudkins R; Vaught J; Mallamo J; Dionne C
Cancer Res; 2003 Sep; 63(18):5978-91. PubMed ID: 14522925
[TBL] [Abstract][Full Text] [Related]
11. Antiproliferative and anticarcinogenic effects of an aqueous preparation of Abies alba and Viscum album se abies, on a L-1210 malignant cell line and tumor-bearing Wistar rats.
Karkabounas S; Assimakopoulos D; Malamas M; Skaltsounis AL; Leonce S; Zelovitis J; Stefanou D; Evangelou A
Anticancer Res; 2000; 20(6B):4391-5. PubMed ID: 11205277
[TBL] [Abstract][Full Text] [Related]
12. Standardized mistletoe extract augments immune response and down-regulates local and metastatic tumor growth in murine models.
Braun JM; Ko HL; Schierholz JM; Beuth J
Anticancer Res; 2002; 22(6C):4187-90. PubMed ID: 12553054
[TBL] [Abstract][Full Text] [Related]
13. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma.
Duong Van Huyen JP; Delignat S; Bayry J; Kazatchkine MD; Bruneval P; Nicoletti A; Kaveri SV
Cancer Lett; 2006 Nov; 243(1):32-7. PubMed ID: 16412563
[TBL] [Abstract][Full Text] [Related]
15. Immunopharmacological and antitumor effects of second-generation immunomodulatory oligonucleotides containing synthetic CpR motifs.
Wang D; Li Y; Yu D; Song SS; Kandimalla ER; Agrawal S
Int J Oncol; 2004 Apr; 24(4):901-8. PubMed ID: 15010828
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts.
Petrangolini G; Pratesi G; De Cesare M; Supino R; Pisano C; Marcellini M; Giordano V; Laccabue D; Lanzi C; Zunino F
Mol Cancer Res; 2003 Oct; 1(12):863-70. PubMed ID: 14573787
[TBL] [Abstract][Full Text] [Related]
17. An overview on anticancer activities of the Viscum album extract Isorel.
Zarkovic N; Vukovic T; Loncaric I; Miletic M; Zarkovic K; Borovic S; Cipak A; Sabolovic S; Konitzer M; Mang S
Cancer Biother Radiopharm; 2001 Feb; 16(1):55-62. PubMed ID: 11279798
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effect of Korean mistletoe (Viscum album coloratum) extract on tumour angiogenesis and metastasis of haematogenous and non-haematogenous tumour cells in mice.
Yoon TJ; Yoo YC; Choi OB; Do MS; Kang TB; Lee SW; Azuma I; Kim JB
Cancer Lett; 1995 Oct; 97(1):83-91. PubMed ID: 7585483
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms of mistletoe plant extract-induced apoptosis in acute lymphoblastic leukemia in vivo and in vitro.
Seifert G; Jesse P; Laengler A; Reindl T; Lüth M; Lobitz S; Henze G; Prokop A; Lode HN
Cancer Lett; 2008 Jun; 264(2):218-28. PubMed ID: 18314258
[TBL] [Abstract][Full Text] [Related]
20. Synergistic in vivo antitumor effect of the histone deacetylase inhibitor MS-275 in combination with interleukin 2 in a murine model of renal cell carcinoma.
Kato Y; Yoshimura K; Shin T; Verheul H; Hammers H; Sanni TB; Salumbides BC; Van Erp K; Schulick R; Pili R
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4538-46. PubMed ID: 17671140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
